Tribenoside + Lidocaine hydrochloride
This medicine should always be used exactly as described in the patient information leaflet or as directed by a doctor or pharmacist.
Procto-Glyvenol rectal cream is a medicine for the local treatment of external and internal hemorrhoids.
Tribenoside has anti-inflammatory, anti-edematous, analgesic, anti-itching, and anti-damage effects on vascular endothelium.
Lidocaine is a local anesthetic and relieves symptoms caused by hemorrhoids, such as itching, burning, and pain.
Procto-Glyvenol rectal cream acts locally, practically without systemic action.
Before starting treatment with Procto-Glyvenol rectal cream in patients with liver function disorders, consult a doctor.
Procto-Glyvenol rectal cream should be used with caution in patients with severe liver damage.
In addition to the treatment of hemorrhoids with Procto-Glyvenol, it is recommended to maintain proper hygiene of the anal area, use appropriate physical exercises, and follow a suitable diet to maintain a soft stool consistency.
Do not take the medicine orally.
Avoid contact with the eyes.
Do not use this medicine in children, as there are no data on the safety of use in this age group.
No interactions with other medicines have been reported.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or plan to take, including those available without a prescription.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult a doctor or pharmacist before using this medicine.
Procto-Glyvenol rectal cream should not be used during the first 3 months of pregnancy.
Procto-Glyvenol rectal cream can be used from the 4th month of pregnancy and during breastfeeding, provided that the recommended doses are not exceeded.
Procto-Glyvenol rectal cream has no or negligible influence on the ability to drive and use machines.
Cetyl alcohol may cause local skin reactions (e.g., contact dermatitis).
Methyl parahydroxybenzoate and propyl parahydroxybenzoate may cause allergic reactions (possible late reactions).
The medicine packaging contains latex. It may cause severe allergic reactions.
This medicine should always be used exactly as described in the patient information leaflet or as directed by a doctor or pharmacist. If you have any doubts, consult a doctor or pharmacist.
Procto-Glyvenol rectal cream should be used in the morning and evening until the acute symptoms disappear. Then, the dose can be reduced to once a day.
In the case of internal hemorrhoids, the cream should be applied using the enclosed applicator, which should be screwed onto the tube. The applicator is equipped with a protective cap.
Remove the cap before using the cream and replace it after application.
Do not exceed the recommended doses of the medicine.
Avoid contact of the medicine with the eyes.
Wash your hands thoroughly after each use of the medicine.
Do not take the medicine orally.
Do not use this medicine in children, as there are no data on the safety of use in this age group.
Procto-Glyvenol rectal cream should be used until the symptoms disappear.
If after 7 days of use there is no improvement or other, previously unobserved symptoms appear, consult a doctor to rule out other potential causes of these complaints.
No cases of overdose with Procto-Glyvenol rectal cream have been reported. There is no specific antidote for lidocaine.
Overdose should not occur when using the medicine according to the recommended dosage regimen.
In case of overdose, consult a doctor immediately.
Do not use a double dose to make up for a missed dose.
If you have any further doubts about the use of this medicine, consult a doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
To assess the side effects, the following frequency categories have been used:
Rare side effects(more than 1 person in 10,000, less than 1 person in 1,000):
Very rare side effects(may occur in up to 1 person in 10,000):
Very common | occurs in more than 1 person in 10 |
Common | occurs in 1 to 10 people in 100 |
Uncommon | occurs in 1 to 10 people in 1,000 |
Rare | occurs in 1 to 10 people in 10,000 |
Very rare | occurs in less than 1 person in 10,000 |
Unknown | frequency cannot be estimated from available data |
If you experience any side effects, including those not listed in the leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: + 48 22 49 21 301, Fax: + 48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. By reporting side effects, you can help provide more information on the safety of this medicine.
Side effects can also be reported to the marketing authorization holder.
Keep the medicine out of the sight and reach of children.
Do not store above 30°C.
Do not use this medicine after the expiry date stated on the carton and tube after "Expiry date". The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Procto-Glyvenol rectal cream is a white, homogeneous cream.
Available packages: Aluminum tube containing 30 g of rectal cream, with a polyethylene cap and latex seal. Polyethylene applicator.
Recordati Ireland Ltd.
Raheens East
Ringaskiddy, Co. Cork
Ireland
RECORDATI Industria Chimica e Farmaceutica S.p.A.
Via Civitali, 1
20148 Milan
Italy
VAMFARMA S.R.L.
Via Kennedy, 5
26833 Comazzo (LO)
Italy
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.